BioArctic AB (publ) (BRCTF)
USD 15.67
(0.0%)
USD 15.67
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 615.99 Million SEK | 169.83% |
| 2022 | 228.29 Million SEK | 886.31% |
| 2021 | 23.14 Million SEK | -62.88% |
| 2020 | 62.34 Million SEK | -77.87% |
| 2019 | 281.77 Million SEK | -60.53% |
| 2018 | 713.97 Million SEK | 407.42% |
| 2017 | 140.7 Million SEK | 33.23% |
| 2016 | 105.61 Million SEK | 154.04% |
| 2015 | 41.57 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 49.84 Million SEK | 68.17% |
| 2024 Q1 | 29.63 Million SEK | 168.86% |
| 2023 Q3 | 208.83 Million SEK | 7617.59% |
| 2023 Q4 | 11.02 Million SEK | -94.72% |
| 2023 Q2 | 2.7 Million SEK | -99.31% |
| 2023 Q1 | 393.42 Million SEK | 18724.21% |
| 2023 FY | 615.99 Million SEK | 169.83% |
| 2022 Q3 | 218.22 Million SEK | 5046.82% |
| 2022 FY | 228.29 Million SEK | 886.31% |
| 2022 Q4 | 2.09 Million SEK | -99.04% |
| 2022 Q2 | 4.24 Million SEK | 13.46% |
| 2022 Q1 | 3.73 Million SEK | -20.59% |
| 2021 FY | 23.14 Million SEK | -62.88% |
| 2021 Q2 | 7.31 Million SEK | 1.88% |
| 2021 Q3 | 3.95 Million SEK | -45.95% |
| 2021 Q4 | 4.7 Million SEK | 19.08% |
| 2021 Q1 | 7.17 Million SEK | -14.16% |
| 2020 Q1 | 36.43 Million SEK | 37.88% |
| 2020 Q4 | 8.36 Million SEK | -20.74% |
| 2020 Q3 | 10.54 Million SEK | 50.55% |
| 2020 Q2 | 7 Million SEK | -80.77% |
| 2020 FY | 62.34 Million SEK | -77.87% |
| 2019 Q4 | 26.42 Million SEK | 28.07% |
| 2019 Q2 | 171.33 Million SEK | 170.29% |
| 2019 Q1 | 63.38 Million SEK | -87.7% |
| 2019 FY | 281.77 Million SEK | -60.53% |
| 2019 Q3 | 20.63 Million SEK | -87.96% |
| 2018 Q2 | 52.3 Million SEK | -0.0% |
| 2018 FY | 713.97 Million SEK | 407.42% |
| 2018 Q4 | 515.32 Million SEK | 447.95% |
| 2018 Q3 | 94.04 Million SEK | 79.81% |
| 2018 Q1 | 52.3 Million SEK | 2.51% |
| 2017 Q1 | 26.17 Million SEK | -72.29% |
| 2017 FY | 140.7 Million SEK | 33.23% |
| 2017 Q2 | 32.01 Million SEK | 22.33% |
| 2017 Q4 | 51.02 Million SEK | 62.01% |
| 2017 Q3 | 31.49 Million SEK | -1.64% |
| 2016 Q1 | 4.99 Million SEK | 0.0% |
| 2016 FY | 105.61 Million SEK | 154.04% |
| 2016 Q4 | 94.44 Million SEK | 7889.85% |
| 2016 Q3 | 1.18 Million SEK | 18.08% |
| 2016 Q2 | 1 Million SEK | -79.96% |
| 2015 FY | 41.57 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -3805.376% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -3495700.465% |
| SQZ Biotechnologies Company | 21.47 Million USD | -2768.028% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -3281.244% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | -400.997% |
| Mesoblast Limited | 5.9 Million USD | -10337.055% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Genus plc | 668.8 Million USD | 7.895% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -150082.244% |
| Marizyme, Inc. | 645.81 Thousand USD | -95283.317% |
| ContraFect Corporation | - USD | -Infinity% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -802384.334% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -937088.109% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -1558670.687% |
| MultiCell Technologies, Inc. | 49.32 USD | -1248975974.615% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -1138.903% |
| EV Biologics, Inc. | 48.9 Thousand USD | -1259603.476% |
| Q BioMed Inc. | 284.35 Thousand USD | -216531.147% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -1981.275% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 245.31 Million USD | -151.103% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -879892.857% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -622154.884% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -813373.932% |
| IMV Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -93445.178% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 95.807% |
| Halberd Corporation | 999.00 USD | -61661061.161% |
| Enzolytics Inc. | 52.79 Thousand USD | -1166645.587% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.36 Million USD | -44895.982% |
| SYBLEU INC | 11.69 Thousand USD | -5266615.116% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -101127.558% |
| argenx SE | 1.22 Billion USD | 49.769% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -31783.799% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -99675.018% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 839.52 Million USD | 26.626% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | -324.532% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -110350.772% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -61639.897% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -1173.928% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 16.68 Million USD | -3591.819% |
| ONE Bio Corp. | 52.29 Million USD | -1077.896% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -260296.939% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -260296.939% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -439137.176% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -129930.819% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -7808.525% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -4738323.077% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -1558039.829% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -18398.348% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -9142.236% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -59187.295% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -2290.635% |
| CSL Limited | 14.8 Billion USD | 95.838% |
| Cellectis S.A. | 755 Thousand USD | -81488.742% |